This article shares third-party research for educational and general wellness purposes only. It is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease. If you are noticing changes in your body or have questions about your health, please consult a knowledgeable healthcare provider.

A literature review published in The Lancet Diabetes & Endocrinology explored the link between menopause and cardiometabolic health in women. The researchers found that the menopausal transition is associated with an increase in fat mass (predominantly in the truncal region), an increase in insulin resistance, dyslipidaemia, and endothelial dysfunction. Exposure to endogenous oestrogen during the reproductive years is associated with protection against cardiovascular disease — a protective effect that research suggests is diminished around 10 years after the onset of menopause.

The researchers also found that women with vasomotor symptoms during menopause appear to have a less favourable cardiometabolic profile. The study's authors note that early attention to traditional cardiovascular risk factors — including hypertension, obesity, diabetes, dyslipidaemia, and smoking — is considered important in this context. The review also highlights female-specific reproductive history factors (such as gestational hypertension or diabetes, premature ovarian insufficiency, and certain gynaecological conditions) that may be relevant to cardiovascular health during and after the menopausal transition.

Link: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00076-6/fulltext